SNPX · Synaptogenix, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $388.8K | - | $203.4K | $4.0K | - | - | - | - | - | - |
| Cost of Revenue | $17.4K | - | - | - | - | - | - | - | - | - |
| Gross Profit | $371.4K | - | - | - | - | - | - | - | - | - |
| R&D | $28.6K | - | $54.4K | $148.6K | $60.8K | - | $222.9K | $342.1K | $609.2K | - |
| SG&A | $1.68M | - | $1.95M | $2.19M | $1.01M | - | $1.14M | $1.24M | $1.08M | - |
| Total Operating Expenses | $1.71M | - | $2.00M | $3.04M | $1.07M | - | $1.36M | $1.58M | $1.69M | - |
| D&A | $816 | - | - | - | $1.0K | - | - | - | $1.4K | - |
| Operating Income | ($1.32M) | - | ($1.98M) | ($1.58M) | $385.2K | - | ($5.74M) | ($1.27M) | ($206.7K) | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $0 | - | - | - | - | - | - | - | - | - |
| Net Income | $4.25M | - | ($3.92M) | ($17.52M) | $385.2K | - | ($5.74M) | ($1.27M) | ($206.7K) | - |
| EPS - Basic | $0.45 | - | ($1.56) | ($11.26) | $0.12 | - | $4.58 | $1.18 | ($0.41) | - |
| EPS - Diluted | $0.43 | - | ($1.56) | ($11.26) | $0.04 | - | $4.58 | - | ($0.41) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.65M | $5.50M | $1.45M | $14.37M | $14.83M | $17.66M | $19.63M | $24.98M | $26.33M | $28.66M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $946.3K | $1.18M | $949.6K | $898.2K | $114.2K | $317.3K | $286.4K | $475.3K | $238.9K | $444.6K |
| Current Assets | $30.24M | $25.38M | $18.35M | $19.78M | $15.32M | $17.72M | $22.28M | $27.83M | $28.83M | $30.53M |
| Total Assets | $31.05M | $25.84M | $18.36M | $19.79M | $15.33M | $17.73M | $22.83M | $28.39M | $29.40M | $31.11M |
| Current Liabilities | $1.10M | $1.81M | $1.04M | $964.3K | $210.7K | $1.01M | $340.9K | $9.35M | $6.30M | $4.28M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $4.88M | $3.94M | $1.69M | $1.83M | $8.88M | $10.96M | $9.71M | $9.59M | $6.52M | $5.53M |
| Stockholders' Equity | $23.26M | $21.05M | $16.07M | $17.25M | $5.17M | $5.86M | $12.80M | $18.80M | $22.05M | $24.35M |
| Retained Earnings | ($72.15M) | ($76.20M) | ($68.47M) | ($64.50M) | ($46.89M) | ($47.17M) | ($41.51M) | ($35.46M) | ($34.04M) | ($33.61M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($1.68M) | - | - | - | ($2.00M) | - | - | - | ($1.83M) | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - | ($500.0K) | - |
| Financing Cash Flow | ($169.0K) | - | - | - | ($822.4K) | - | - | - | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 95.5% | - | - | - | - | - | - | - | - | - |
| Operating margin | -339.0% | - | -972.6% | -39903.3% | - | - | - | - | - | - |
| EBITDA margin | -338.7% | - | - | - | - | - | - | - | - | - |
| Net margin | 1094.3% | - | -1929.1% | -442101.9% | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | 7.4% | - | 26.7% | 3749.5% | - | - | - | - | - | - |
| SG&A / Revenue | 431.6% | - | 958.1% | 55310.3% | - | - | - | - | - | - |
| Effective tax rate | 0.0% | - | - | - | - | - | - | - | - | - |
| Return on assets | 13.7% | - | -21.4% | -88.5% | 2.5% | - | -25.2% | -4.5% | -0.7% | - |
| Return on equity | 18.3% | - | -24.4% | -101.5% | 7.5% | - | -44.9% | -6.8% | -0.9% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 27.40 | 13.99 | 17.61 | 20.51 | 72.71 | 17.47 | 65.36 | 2.98 | 4.58 | 7.14 |
| Quick ratio | 27.40 | 13.99 | 17.61 | 20.51 | 72.71 | 17.47 | 65.36 | 2.98 | 4.58 | 7.14 |
| Cash ratio | 3.30 | 3.03 | 1.39 | 14.90 | 70.41 | 17.41 | 57.57 | 2.67 | 4.18 | 6.70 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.33 | 1.23 | 1.14 | 1.15 | 2.97 | 3.02 | 1.78 | 1.51 | 1.33 | 1.28 |
| Liabilities / Assets | 0.16 | 0.15 | 0.09 | 0.09 | 0.58 | 0.62 | 0.43 | 0.34 | 0.22 | 0.18 |
| Efficiency | ||||||||||
| Asset turnover | 0.01 | - | 0.01 | 0.00 | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | 19887d | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | 65.6% | -24.2% | - | - | - | 68.9% | 87.9% | - |
| Net income growth (YoY) | 1004.6% | - | 31.7% | -1275.6% | - | - | - | 68.9% | 87.9% | - |
| EPS growth (YoY) | 975.0% | - | - | - | - | - | 15166.7% | - | - | - |
| EPS CAGR (3y) | 18.3% | - | - | - | -56.0% | - | 113.6% | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 350.0% | 259.0% | 25.5% | -8.2% | -76.6% | -75.9% | -52.1% | -24.3% | -29.9% | -25.5% |
Peer comparison
Same SIC group: Finance Services
Comparing Synaptogenix against the 5 most active filers in the same SIC group.